Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease-Reference-Cited by-同舟云学术

Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease

Published:2017-11 Issue:9 Volume:33 Page:678-685
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Steven Philipp¹²,Augustin Albert J.³,Geerling Gerd⁴,Kaercher Thomas⁵,Kretz Florian⁶,Kunert Kathleen⁷,Menzel-Severing Johannes⁸,Schrage Norbert⁹,Schrems Wolfgang⁸,Krösser Sonja¹⁰,Beckert Michael¹¹,Messmer Elisabeth M.¹²

Affiliation:

1. Department of Ophthalmology and Ocular GvHD Competence Center, Medical Faculty, University of Cologne, Cologne, Germany.

2. Cluster of Excellence: Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

3. Department of Ophthalmology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany.

4. Department of Ophthalmology, Heinrich-Heine-University, Duesseldorf, Germany.

5. Ophthalmology Clinics, Heidelberg, Germany.

6. Department of Ophthalmology, International Vision Correction Research Centre (IVCRC) and David J Apple International Laboratory for Ocular Pathology, University of Heidelberg, Heidelberg, Germany.

7. JENVIS Research, Ernst-Abbe-University of Applied Sciences, Jena, Germany.

8. Department of Ophthalmology, University of Erlangen-Nuermberg, Erlangen, Germany.

9. Department of Ophthalmology, Kliniken der Stadt Köln, Cologne, Germany.

10. Novaliq GmbH, Heidelberg, Germany.

11. CaRACS—Clinical and Regulatory Affairs Consulting Services, Berlin, Germany.

12. Department of Ophthalmology, Ludwig Maximilian University, Munich, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2017.0042